USE OF KETOROLAC FOR TREATMENT OF SQUAMOUS CELL CARCINOMAS OF THE ORAL CAVITY OR OROPHARYNX

摘要

The present invention provides novel methods for prevention or treatment ofprimary and recurring squamous cell carcinoma of the oral cavity or oropharynxcomprising topical administration, to the oral cavity or oropharynx, of aneffective amount of an NSAID, especially a composition administering fromabout 0.0001 % to about 0.2 % ketorolac to the oral cavity, alone or as anadjunct to surgery and/or radiation therapy.